ClinicalTrials.gg
RecruitingNCT06896032Updated Apr 16, 2025

Retro-walking Versus Forward-walking Training Using Underwater Treadmill in Patients With Knee Osteoarthritis

An interventional study of physical therapy intervention in Knee Osteoarthritis (Knee OA) and Osteoarthritis, sponsored by Nourhan Atwa Said. Recruiting at 2 sites in Egypt. Open to participants aged 40 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-16.

Sponsored by Nourhan Atwa Said · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Mar 2025; still recruiting 1 year 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 91 studies in Osteoarthritis, Knee with a site in Egypt — 28 open to participants now, 34 under way, 1 of them phase 3. Osteoarthritis, Knee · Egypt.

Planned enrollment
43rd of 83
60 · median 62
Started
2025
with 10 others
No phase
76 of 91
22 open now
Primary completion
2025-06
later than 10 of 33 live
Registered
60th of 91
by date

Among the 91 studies in Osteoarthritis, Knee with a site in Egypt, this one is the 43rd largest by planned enrollment of the 83 interventional ones that give a count, is one of 11 that started in 2025, is one of 76 with no phase, reaches primary completion later than 10 of the 33 other live ones, and was the 60th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

28 of the 91 studies in Osteoarthritis, Knee with a site in Egypt are open now. Recruiting first, the newest first:

22 more — sign in →

All 28 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 40 Years to 60 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 91 studies in Osteoarthritis, Knee with a site in Egypt, or all of them as a file.
02

Study summary

The purpose of this study Will investigate and compare the effects of retro-walking and forward-walking underwater treadmill training on pain, function and ROM in subjects with chronic knee OA

Read the detailed description

In the current study, Sixty subjects from both genders, the dominant side only will be involved. They will be divided in to three equal groups: group A (experimental1), group B (experimental 2), group C (control), they will be signed a consent form to share in this study which aimed to investigate the effects of retro-walking and forward-walking underwater treadmill training on pain, function and ROM in subjects with chronic knee OA

03

Conditions studied

  • Knee Osteoarthritis (Knee OA)
  • Osteoarthritis

Keywords

  • Knee Osteoarthritis
04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 60 patients with chronic knee OA.
  2. Age ranges from 40-60 years old of both genders.
  3. (BMI) 25- 35kg/m2.
  4. The degree of osteoarthritis was mild or moderate and have a Kellgren- Lawrence radiographic grade of of1-3.
  5. unilateral knee osteoarthritis involvement.

Exclusion criteria

Exclusion Criteria:

  1. hydrophobia.
  2. pregnancy.
  3. infection.
  4. psychiatric disorder.
  5. haemorrhagic diathesis.
  6. cardiac pacemaker.
  7. all Subjects with deformity of hip, knee \& ankle.
  8. any CNS or PNS involvement.
  9. recent steroidal or intraarticular injections (3 months).
  10. systemic inflammatory disease and bone .
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    group A (experimental1)

    forward walking group

    Other: physical therapy intervention

  • Experimental
    group B (experimental 2)

    retro walking group

    Other: physical therapy intervention

  • Other
    group c

    control group

    Other: physical therapy intervention

Interventions

  • Otherphysical therapy intervention

    retro-walking and forward-walking underwater treadmill training

    Also known as: hydro therapy, aquatic therapy

06

What researchers measure

Primary outcomes

  1. Pain intensity

    Pain intensity will be measured by visual analog scale (VAS. ). It is line with worst pain at one end and no pain at the other end

    Time frame: up to three monthes

  2. knee disability

    knee disablity will be measured by The Western Ontario and McMaster Universities osteoarthritis index. The WOMAC is a self-administered instrument containing 24 items measuring 3 subscales: physical function (17 items), pain (5 items), and stiffness (2 items).Scores range from 0 to 96 for the total WOMAC where 0 represents the best health status and 96 the worst possible status.

    Time frame: up to three months

Secondary outcomes

  1. knee range of motion

    knee joint rang of motion will be measured by goniometer

    Time frame: up to three months

07

Study locations

2 of 2 sites recruiting
  • cairo U
    Cairo, 02, Egypt
    Enrolling by invitation
  • cairo U
    Cairo, 02, Egypt
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Jun 2025, 3 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 3 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 22, 2025
First posted
Mar 26, 2025
StartActual
Mar 30, 2025
Primary completionEst.
Jun 30, 2025
CompletionEst.
Jul 25, 2025
Last update
Apr 16, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06896032
Lead sponsor
Nourhan Atwa Said
Collaborators
Cairo University
Responsible party
Nourhan Atwa Said (physical therapist, Cairo University) — Sponsor-investigator
First posted
Mar 26, 2025
Start date
Mar 30, 2025
Primary completion
Jun 30, 2025 (estimated)
Completion
Jul 25, 2025 (estimated)
Last update
Apr 16, 2025

Study contacts

nourhan atwa said, bacalora
Contact
nourhan.atwa@icloud.com
+201005074315 ext. +201023770486

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion